Overview

Study of T-PRED(TM) Compared to Pred Forte(R) II

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Study of T-PRED(TM) Compared to Pred Forte(R)
Phase:
Phase 3
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Ophthalmic Solutions
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Prednisone